NDC 62856-274 – Fycompa
Perampanel 4 mg/1 · Tablet · Oral
Product NDC62856-274
Product details
- Brand name
- Fycompa
- Generic name
- Perampanel
- Labeler
- Eisai Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- NDA · NDA202834
- Marketed since
- October 22, 2012
- Listing expires
- December 31, 2027
- Pharmacologic class
- Noncompetitive AMPA Glutamate Receptor Antagonist
Active ingredients
- Perampanel 4 mg/1
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 62856-274-14 sample | 14 TABLET in 1 PACKET (62856-274-14) | Aug 8, 2018 |
| 62856-274-30 | 30 TABLET in 1 BOTTLE (62856-274-30) | Oct 22, 2012 |
| 62856-274-90 | 90 TABLET in 1 BOTTLE (62856-274-90) | Oct 22, 2012 |
Other Fycompa products
- 69616-272 Perampanel 2 mg/1 · Tablet · Catalyst Pharmaceuticals, Inc.
- 69616-274 Perampanel 4 mg/1 · Tablet · Catalyst Pharmaceuticals, Inc.
- 69616-276 Perampanel 6 mg/1 · Tablet · Catalyst Pharmaceuticals, Inc.
- 69616-278 Perampanel 8 mg/1 · Tablet · Catalyst Pharmaceuticals, Inc.
- 69616-280 Perampanel 10 mg/1 · Tablet · Catalyst Pharmaceuticals, Inc.
- 69616-282 Perampanel 12 mg/1 · Tablet · Catalyst Pharmaceuticals, Inc.
- 62856-272 Perampanel 2 mg/1 · Tablet · Eisai Inc.
- 62856-276 Perampanel 6 mg/1 · Tablet · Eisai Inc.
- 62856-278 Perampanel 8 mg/1 · Tablet · Eisai Inc.
- 62856-280 Perampanel 10 mg/1 · Tablet · Eisai Inc.
- 62856-282 Perampanel 12 mg/1 · Tablet · Eisai Inc.
- 69616-290 Perampanel .5 mg/mL · Suspension · Catalyst Pharmaceuticals, Inc.